• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • M&C Reacts

Biomedical businesses booming in Cambridge

Biomedicine in Cambridge
04 April 2022
Jasmine Percival
Print
Share

Marks & Clerk was were delighted to attend the launch event of the 2022 Cambridge Biomedical Cluster map, an insightful project undertaken by letscellit.com in collaboration with Brockton Everlast. The cluster map highlights the breadth and depth of the biomedical landscape of Cambridge, with a host of diverse biomedical companies having a base here, as well as a world leading university, hospitals and research institutes.

The map shows that the Cambridge Biomedical Cluster is an epicentre for new businesses and innovation, with 52% of the cluster being classed as micro-enterprises. However, Cambridge is not short of small – medium and large enterprises, hosting 7 of the world’s top pharmaceutical companies, offering a unique hub of biomedical expertise and innovation, with opportunities for collaboration. The 397 biomedical companies forming the cluster shows that Cambridge remains a key player in the biomedical supply chain. The cluster includes a range of companies that develop biomedical instrumentation, research tools and reagents, contributing to Cambridge’s position as a leader in biomedical research and innovation. Cambridge is also a major player in therapeutics, with a wide range of therapeutic companies undertaking leading R&D being based here, with a strong force of enterprises focusing on oncology therapeutics.

It is particularly exciting to see from the updated 2022 Cambridge Biomedical Cluster map that there was a 49% increase in companies created in the 2010’s compared to the previous decade, and an average of 1 new company per month in the last 2 years. This highlights that the biomedical landscape in Cambridge is expanding. In particular, there has been growth in enterprises working in the area of medical devices. This is a rapidly moving field bringing together expertise from different areas, with Cambridge as a hub of technical excellence as well as biomedical excellence. We anticipate some breakthrough technologies will arise from growth in this area.

At Marks & Clerk, we have worked with several companies on the cluster map and have helped them protect their IP assets. We have in-depth knowledge across biomedical technologies including drug delivery, surgical equipment, diagnostic methods, small molecules and immunology. In addition to our vast expertise in biomedical technologies we have attorneys with expertise across emerging areas at the forefront of development of new medical technologies such as AI and machine learning and personalised medicine.

If you require intellectual property advice, please get in touch.

Next Story
  • Cook v Boston – practicalities relating to the Shorter Trial Scheme and costs budgeting
  • Patenting DLT innovations in Europe
  • Applications of DLTs
  • Windtech International: Will European IP be the key for overseas countries in meeting their Net Zero targets?
  • What makes a good Patent Attorney?
More insights

Latest Insights

Photo: Gavel and Justice Scale
Article
- 11 August 2022

Cook v Boston – practicalities relating to the Shorter Trial Scheme and costs budgeting

The Shorter Trial Scheme (STS) was set up with the purpose of providing parties with an avenue to achieve earlier, shorter trials for reasonably sized litigation at a proportionate cost. The judgment in proceedings between Cook and Boston contains a few practical points on the STS and other case management issues.
Read more
News
- 10 August 2022

Marks & Clerk’s trade mark team also celebrates exam success!

In addition to our excellent patent team results in July, we are also thrilled to announce that several members of the Marks & Clerk Trade Mark team are enjoying exam success.
Read more
Blockchain/cryptocurrency concept: 3D cubes
Article
- 05 August 2022

Patenting DLT innovations in Europe

In Europe, inventions that utilise distributed ledger technology will generally fall under the heading of “computer-implemented inventions (CIIs).”
Read more
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Lexology
  • Mondaq